telomere disease
Jump to navigation
Jump to search
Etiology
- dyskeratosis congenita in children
Pathology
- more rapid shortening of telomeres with cell division
- aplastic anemia
- pulmonary fibrosis
- liver cirrhosis
- leukoplakia
- reduced telomer length associate with increased overall motality (RR=1.08), cardiovascular mortality (RR=1.09), respiratory mortality (RR=1.40), digestive system mortality (RR=1.26), musculoskeletal mortality (RR=1.51), & COVID-19 mortality (RR=1.15) mortality, but not cancer-related mortality[2]
Management
More general terms
More specific terms
Additional terms
References
- ↑ 1.0 1.1 Townsley DM et al. Danazol treatment for telomere diseases. N Engl J Med 2016 May 19; 374:1922 PMID: https://www.ncbi.nlm.nih.gov/pubmed/27192671
Lansdorp PM. Telomeres on steroids - turning back the mitotic clock? N Engl J Med 2016 May 19; 374:1978 PMID: https://www.ncbi.nlm.nih.gov/pubmed/27192677 - ↑ 2.0 2.1 Schneider CV, Schneider KM, Teumer A et al Association of Telomere Length With Risk of Disease and Mortality. JAMA Intern Med. Published online January 18, 2022 PMID: https://www.ncbi.nlm.nih.gov/pubmed/35040871 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2788295